AI assistant
Sending…
EROAD Limited — Director's Dealing 2018
Mar 8, 2018
66188_rns_2018-03-09_64ba4b31-6a94-49bd-b332-0b69c5f4ae18.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [76 x 21] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EROAD Limited | |
| Date this disclosure made: | 7 March 2018 | |
| Date of last disclosure: | 15 August 2014 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | Michael Bruce Bushby | |
| Name of listed issuer: | EROAD Limited | |
| Name of related body corporate (if applicable): | Not applicable | |
| Position held in listed issuer: | Independent Board Chairman |
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
| Class of affected quoted financial products: | Ordinary shares in EROAD Limited(ERD) |
||
|---|---|---|---|
| Nature of the affected relevant interest(s): | Michael Bushby is a director of Lowelly Pty Limited and accordingly has the power to control dealings and voting of shares held by Lowelly Pty Limited as trustee for the Lowelly Superannuation Fund. Michael Bushby is also a beneficiary of the Lowelly Superannuation Fund. |
||
| For that relevant interest- | |||
| Number held in class before acquisition or disposal: | 132,737 | ||
| Number held in class after acquisition or disposal: | 137,671 | ||
| Current registered holder(s): | Lowelly Pty Limited as trustee for the Lowelly Superannuation Fund |
||
| Registered holder(s) once transfers are registered: | Not applicable |
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
| Type of affected derivative: | Not applicable | |
|---|---|---|
| Class of underlyingfinancialproducts: | Not applicable | |
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial products(if any): |
Not applicable | |
| A statement as to whether the derivative is cash settled orphysicallysettled: | Not applicable | |
| Maturitydate of the derivative(if any): | Not applicable | |
| Expirydate of the derivative(if any): | Not applicable | |
| Theprice specified in the terms of the derivative(if any): | Not applicable | |
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financial products: |
Not applicable | |
| _For that derivative,- _ | ||
| Parties to the derivative: | Not applicable | |
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Not applicable |
Details of transactions giving rise to acquisition or disposal
| Details of transactions requiring disclosure- | Details of transactions requiring disclosure- | Details of transactions requiring disclosure- | Details of transactions requiring disclosure- |
|---|---|---|---|
| Date of transaction: | |||
| Nature of transaction: | |||
| Name of anyotherpartyorparties to the transaction(if known): | |||
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value,describe the consideration: |
|||
| Number of financialproducts to which the transaction related: | |||
| If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— |
|||
| Whether relevant interests were acquired or disposed of duringa closedperiod: | No | ||
| Whether prior written clearance was provided to allow the acquisition or disposal to proceed duringthe closedperiod: |
Not applicable | ||
| Date of theprior written clearance(if any): | Not applicable | ||
| Summary of other relevant interests after acquisition or disposal: Class ofquoted financialproducts: Nature of relevant interest: For that relevant interest,- Number held in class: Current registered holder(s): For a derivative relevant interest,- Type of derivative: Details of derivative,- |
|||
| The notional value of the derivative (if any) or the notional amount of underlying financial products (if any): |
Not applicable | ||
| A statement as to whether the derivative is cash settled or physically settled: | Not applicable | ||
| Maturity date of the derivative (if any): | Not applicable | ||
| Expiry date of the derivative (if any): | Not applicable | ||
| The price's specified terms (if any): | Not applicable | ||
| Any other details needed to understand how the amount of the consideration payable under the derivative or the value of the derivative is affected by the value of the underlying financialproducts: |
Not applicable | ||
| For that derivative relevant interest,- | Not applicable | ||
| Parties to the derivative: | Not applicable | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant interest in the derivative: |
Not applicable | ||
| 7 March 2018 | |||
| Certification I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. Signature of director or officer: Date of signature: or Signature of person authorised to sign on behalf of director or officer: Date of signature: Name and title of authorisedperson: |
|||
| Signature of person authorised to sign on behalf of director or officer: | |||
| Date of signature: | |||
| Name and title of authorisedperson: |
More from EROAD Limited
Major Shareholding Notification
2026
Jun 8
Director's Dealing
2026
Jun 8
Major Shareholding Notification
2026
May 28
Major Shareholding Notification
2026
May 27
Report Publication Announcement
2026
May 27
Share Issue/Capital Change
2026
May 27
Proxy Solicitation & Information Statement
2026
May 25
Earnings Release
2026
May 24
Report Publication Announcement
2026
May 24
Board/Management Information
2026
May 21